Table 1.
Patient characeeristics and flare reactions
| Patient no./age/sex | Primary site | Prior therapy | Flare type (CTCAE score) | Mitigation success |
|---|---|---|---|---|
| 1/69/f | Sm bowel | SSA, temozolomide | Cranial nerve dysfunction (2) | Fair |
| 2/46/f | Sm bowel | SSA, pall RT | Bone pain (2) | Good |
| 3/68/m | Pancreas | SSA, everolimus, Y90 and chemo emb | ||
| 4/57/f | Sm bowel | SSA | ||
| 5/68/f | Sm bowel | SSA, bland and Y90 emb | Epigastric pain (2) | Fair |
| 6/56/m | Sm bowel | SSA, TACE | Small bowel dysfunction (2) | Fair |
| 7/47/f | Sm bowel | SSA | pSBO (3) | Good |
| 8/65/f | Kidney | SSA | ||
| 9/68/m | Sm bowel | SSA, Y90 | ||
| 10/77/f | Sm bowel | SSA, TACE, ablation. Liver resection | ||
| 11/73/f | Sm bowel | SSA, TACE, everolimus, Y90 | ||
| 12/45/m | Pancreas | SSA, everolimus |
Abbreviations: CTCAE = Common Terminology Criteria for Adverse Events; emb = embolization; pall = palliative; pSBO = partial small bowel obstruction; RT = radiation therapy; sm = small; SSA = somatostatin analog therapy; TACE = transarterial chemoembolization.